Product Highlight - Bexsero

Active ingredient: Multicomponent meningococcal group B vaccine (recombinant, adsorbed)

Indications: Active immunisation of individuals from ≥2 mth against invasive meningococcal disease caused by Neisseria meningitidis group B.

Dosage & Administration: Deep IM inj Preferably in anterolateral aspect of thigh in infants or deltoid muscle region of upper arm in older subject. Infant 2-5 mth Primary immunisation: 2 doses each of 0.5 mL. Interval between primary doses: Not <2 mth; Primary immunisation: 3 doses each of 0.5 mL. Interval between primary doses: Not <1 mth. Booster dose: 1 dose in 2nd year of life w/ an interval of at least 6 mth between primary series & booster dose; 6-11 mth Primary immunisation: 2 doses each of 0.5 mL. Interval between primary doses: Not <2 mth. Booster dose: 1 dose in 2nd yr of life w/ an interval of at least 2 mth between primary series & booster dose. Childn 12-23 mth Primary immunisation: 2 doses each of 0.5 mL. Interval between primary doses: Not <2 mth. Booster dose: 1 dose w/ an interval of 12-23 mth between primary series & booster dose. Childn 2-10 yr, adult & adolescent (from 11 yr) Primary immunisation: 2 doses each of 0.5 mL. Interval between primary doses: Not <1 mth. Booster dose: Consider in individuals at continued risk of exposure to meningococcal disease, based on official recommendations.